DE68928710T2 - T-Zellen-Wachstumsfaktor - Google Patents

T-Zellen-Wachstumsfaktor

Info

Publication number
DE68928710T2
DE68928710T2 DE68928710T DE68928710T DE68928710T2 DE 68928710 T2 DE68928710 T2 DE 68928710T2 DE 68928710 T DE68928710 T DE 68928710T DE 68928710 T DE68928710 T DE 68928710T DE 68928710 T2 DE68928710 T2 DE 68928710T2
Authority
DE
Germany
Prior art keywords
growth factor
cells
cell growth
helper
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68928710T
Other languages
English (en)
Other versions
DE68928710D1 (de
Inventor
Snick Jacques Van
Catherine Uyttenhove
Richard J Simpson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research New York
Original Assignee
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research New York
Publication of DE68928710D1 publication Critical patent/DE68928710D1/de
Application granted granted Critical
Publication of DE68928710T2 publication Critical patent/DE68928710T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5425IL-9
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/14Lymphokine; related peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/14Lymphokine; related peptides
    • Y10S930/141Interleukin
DE68928710T 1988-09-19 1989-09-19 T-Zellen-Wachstumsfaktor Expired - Lifetime DE68928710T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/246,482 US5208218A (en) 1988-09-19 1988-09-19 T cell growth factor glycoproteins

Publications (2)

Publication Number Publication Date
DE68928710D1 DE68928710D1 (de) 1998-07-23
DE68928710T2 true DE68928710T2 (de) 1999-02-11

Family

ID=22930867

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68928710T Expired - Lifetime DE68928710T2 (de) 1988-09-19 1989-09-19 T-Zellen-Wachstumsfaktor

Country Status (12)

Country Link
US (2) US5208218A (de)
EP (1) EP0361284B1 (de)
JP (1) JP3223260B2 (de)
AT (1) ATE167519T1 (de)
AU (1) AU621661B2 (de)
CA (1) CA1341461C (de)
DE (1) DE68928710T2 (de)
DK (1) DK175845B1 (de)
ES (1) ES2118058T3 (de)
IE (1) IE81152B1 (de)
IL (1) IL91691A (de)
PT (1) PT91750B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208218A (en) * 1988-09-19 1993-05-04 Ludwig Institute For Cancer Research T cell growth factor glycoproteins
US5587302A (en) * 1988-09-19 1996-12-24 Ludwig Institute For Cancer Research T cell growth factor
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9
US5414071A (en) * 1989-05-23 1995-05-09 Genetics Institute, Inc. Human cytokine IL-9
CA2069090A1 (en) * 1989-11-21 1991-05-22 John A. Hamilton Anti-inflammatory compositions and methods
US5132109A (en) * 1990-10-05 1992-07-21 Ludwig Institute For Cancer Research Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof
US5250295A (en) * 1991-11-04 1993-10-05 The Regents Of The Univ. Of California Natural killer cell enhancing factor
AU5102993A (en) * 1992-09-18 1994-04-12 Merck & Co., Inc. Dna encoding murine precursor interleukin 1beta converting enzyme
TW257792B (de) * 1992-10-01 1995-09-21 Lilly Co Eli
US5643881A (en) * 1994-08-04 1997-07-01 Tampa Bay Research Institute Protein having anti-HIV activity and method for obtaining it
US5908839A (en) * 1995-08-24 1999-06-01 Magainin Pharmaceuticals, Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
ATE484294T1 (de) * 1995-08-24 2010-10-15 Genaera Corp Anti-interleukin-9 antikörper oder anti- interleukin-9 rezeptor antikörper zur behandlung von bronchialem hyperreaktionsvermögen
AU2007202406B2 (en) * 1995-08-24 2010-08-12 Ligand Pharmaceuticals Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
WO1998024904A2 (en) * 1996-12-02 1998-06-11 Magainin Pharmaceuticals Inc. Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
ATE540695T1 (de) 2001-06-08 2012-01-15 Genaera Corp Verfahren zur modulation von il-13
WO2003086458A1 (en) * 2002-04-12 2003-10-23 Medimmune, Inc. Recombinant anti-interleukin-9 antibodies
ATE473239T1 (de) * 2003-05-14 2010-07-15 Bayer Pharmaceuticals Corp Interleukin-9 antagonist-muteine und ihre pharmakologischen anwendungsverfahren
US9808512B2 (en) * 2007-12-28 2017-11-07 Kalos Therapeutics Anti-cell proliferative compounds and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636463A (en) * 1984-04-05 1987-01-13 Scripps Clinic And Research Foundation Antibodies to human interleukin-2 induced by synthetic polypeptides
US5006459A (en) * 1986-03-31 1991-04-09 T Cell Sciences, Inc. Therapeutic and diagnostic methods using soluble T cell surface molecules
US4935343A (en) * 1986-08-08 1990-06-19 Syntex (U.S.A.) Inc. Monoclonal antibodies for interleukin-1β
US5208218A (en) * 1988-09-19 1993-05-04 Ludwig Institute For Cancer Research T cell growth factor glycoproteins
AU5827690A (en) * 1989-05-24 1990-12-18 Abbott Laboratories Atrial peptide derivatives

Also Published As

Publication number Publication date
US5208218A (en) 1993-05-04
AU4156389A (en) 1990-03-22
IL91691A0 (en) 1990-06-10
DE68928710D1 (de) 1998-07-23
DK458889D0 (da) 1989-09-18
EP0361284A2 (de) 1990-04-04
JPH034796A (ja) 1991-01-10
ATE167519T1 (de) 1998-07-15
ES2118058T3 (es) 1998-09-16
JP3223260B2 (ja) 2001-10-29
IL91691A (en) 1997-07-13
PT91750B (pt) 1995-05-31
DK458889A (da) 1990-03-20
AU621661B2 (en) 1992-03-19
IE892983L (en) 1990-03-19
EP0361284B1 (de) 1998-06-17
CA1341461C (en) 2004-10-26
IE81152B1 (en) 2000-05-03
EP0361284A3 (de) 1990-09-05
DK175845B1 (da) 2005-03-29
PT91750A (pt) 1990-03-30
US5157112A (en) 1992-10-20

Similar Documents

Publication Publication Date Title
DE68928710D1 (de) T-Zellen-Wachstumsfaktor
ATE369383T1 (de) Monoklonale antikörper spezifisch für den zytotoxischen lymphozyten-reifefaktor
DK546388D0 (da) Polypeptidvaekstfaktor fra maelk
DE10075011I2 (de) Rezeptoren für Tumornekrosisfaktor-alpha und-beta.
DE3789859T2 (de) Formen des Koloniestimulierungsfaktors 1.
DE69428214T2 (de) Transformierender wachstumsfaktor alpha h1
ATE103494T1 (de) Verwendung von interleukin 2 zur behandlung von leukaemien.
EP0348086A3 (en) Novel peptides, their use as immuno suppressants and processes for their preparation
CA2050477A1 (en) T cell growth factor
Gearing et al. Human B cell proliferation is stimulated by interleukin 2
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
Oppenheim et al. Possible Autoregulatory Roles of Interleukin 1 for Normal Human Epithelial Cells, Monocytes and B Lymphocytes
Van et al. T cell growth factor
Abdullah Regulation of murine interferon-gamma production by epidermal growth factor.
ES8703928A1 (es) Un metodo para preparar la proteina factor de estimulacion de colonias (csf-1)recombinante

Legal Events

Date Code Title Description
8364 No opposition during term of opposition